Harvard Apparatus Regenerative Technology, Inc. (HRGN) insider trading
Harvard Apparatus Regenerative Technology, Inc. insiders have made 1 open-market purchase worth $394k since Sep 25, 2026, by 1 insider. The latest: Junli He (CEO) bought $394k, filed Sep 25, 2026, scored 32 out of 100.
Follow HRGN, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 25 Form 4 (opens sec.gov) |
Junli HeCEO · filed lateCEO · Near 52-week low · Filed late · Penny stock: hard to trade | +38% stake | 32 | $394k 368,630 at $1.07 |
+11.2% | −0.4% |
Track record (hypothetical): a week after the filing, these buys averaged +11.2% (100% up, 1 measured); a month after, −0.4% (0% up, 1 measured).
Insiders who bought HRGN
- Junli He CEO
Questions
Are insiders buying HRGN stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $394k.
Who bought HRGN stock most recently?
Junli He, CEO, bought 368,630 shares for $394k (Form 4 (opens sec.gov), filed Sep 25, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Sep 25, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer